{{Rsnum
|rsid=441051
|Gene=COL1A2
|Chromosome=7
|position=94424688
|Orientation=plus
|GMAF=0.1869
|Gene_s=CHRNA1,COL1A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 63.7 | 29.2 | 7.1
| HCB | 84.6 | 14.7 | 0.7
| JPT | 89.4 | 8.8 | 1.8
| YRI | 48.3 | 46.3 | 5.4
| ASW | 45.6 | 45.6 | 8.8
| CHB | 84.6 | 14.7 | 0.7
| CHD | 75.2 | 23.9 | 0.9
| GIH | 52.5 | 40.6 | 6.9
| LWK | 56.5 | 36.1 | 7.4
| MEX | 74.1 | 22.4 | 3.4
| MKK | 47.4 | 44.2 | 8.3
| TSI | 60.8 | 34.3 | 4.9
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs441051
|PubMedID=17903307
|Condition=Mean forced vital capacity from 2 exams
|Gene=COL1A2
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs441051
|Name_s=
|Gene_s=COL1A2
|Feature=
|Evidence=PubMed ID:17903307; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study genome-wide association: results for pulmonary function measures (Initial Sample Size: 1,097-1,222 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Mean forced vital capacity from 2 exams.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356433
}}

{{PMID Auto
|PMID=20140262
|Title=Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs441051
|overall_frequency_n=99
|overall_frequency_d=128
|overall_frequency=0.773438
|n_genomes=53
|n_genomes_annotated=0
|n_haplomes=87
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}